Global Pharmaceuticals & Biotech Big Green Snowflakes

Lin BioScience

Market Cap: NT$12.7b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

HLB TherapeuticsLtd

Market Cap: ₩254.0b

A biotech company, develops pharmaceutical products in South Korea and internationally.

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd

Market Cap: HK$8.7b

Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.

KoBioLabs

Market Cap: ₩115.0b

Provides microbiome therapeutics for metabolic, immune, and neurological diseases.

Fredun Pharmaceuticals

Market Cap: ₹5.8b

Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products in India, Africa, Southeast Asia, CIS countries, and Latin America.

Kubota Pharmaceutical Holdings

Market Cap: JP¥5.1b

Develops portfolio of drugs and devices worldwide.

CellBion

Market Cap: ₩262.8b

Engages in the research and development of radiopharmaceutical products.

Cytogen

Market Cap: ₩61.6b

A biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea.

BioInfra

Market Cap: ₩26.0b

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

Suven Life Sciences

Market Cap: ₹50.2b

A clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally.

Energenesis BiomedicalLTD

Market Cap: NT$4.8b

Operates in the biomedicine industry in Taiwan.

China Regenerative Medicine International

Market Cap: HK$234.3m

An investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China.

Enimmune

Market Cap: NT$1.5b

Operates as a biopharmaceutical Research and development, and marketing company in Taiwan.

ENCell

Market Cap: ₩125.6b

Develops cell/gene-based biopharmaceutical products in South Korea.

Standard BioTools

Market Cap: US$489.0m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Rekah Pharmaceutical Industry

Market Cap: ₪133.6m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.

CERo Therapeutics Holdings

Market Cap: US$6.0m

An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.

iBio

Market Cap: US$17.3m

A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.

Genflow Biosciences

Market Cap: UK£3.6m

Engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium.

Avidity Biosciences

Market Cap: US$6.0b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Virpax Pharmaceuticals

Market Cap: US$13.8k

A preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders.

ImmuPharma

Market Cap: UK£54.2m

A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.

Cilo Cybin Holdings

Market Cap: R207.4m

Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide.

Fortrea Holdings

Market Cap: US$908.9m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Medicus Pharma

Market Cap: US$36.2m

A biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets.

Moderna

Market Cap: US$9.5b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Brainstorm Cell Therapeutics

Market Cap: US$7.6m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Transgene

Market Cap: €152.2m

A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.

Aquestive Therapeutics

Market Cap: US$590.4m

Operates as a pharmaceutical company in the United States and internationally.

Relief Therapeutics Holding

Market Cap: CHF 36.2m

A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases.

HCW Biologics

Market Cap: US$6.1m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

bioAffinity Technologies

Market Cap: US$7.2m

Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

Inventiva

Market Cap: €658.0m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.

Longevity Health Holdings

Market Cap: US$4.9m

A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.

European Medical Solutions

Market Cap: €18.2m

Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.

Cannovum Cannabis

Market Cap: €924.5k

Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.